Donya Carter
Family · West Haverstraw, NYNPI 1407366735
Payments from drug & device makers
Across 161 payments — averaging $36.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$761
- GSK$584
- Viiv Healthcare Company$564
- AstraZeneca$473
- Idorsia Pharmaceuticals US Inc$376
- Novo Nordisk$320
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,824100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $761 |
| GSK | 17 | $584 |
| Viiv Healthcare Company | 7 | $564 |
| AstraZeneca | 7 | $473 |
| Idorsia Pharmaceuticals US Inc | 8 | $376 |
| Novo Nordisk | 6 | $320 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $229 |
| Amgen(2 entities) | 8 | $212 |
| Pfizer | 10 | $197 |
| Lilly USA, LLC | 6 | $181 |
| Sanofi-aventis U.S. LLC | 4 | $181 |
| Exact Sciences | 5 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $140 |
| Braeburn Inc. | 7 | $136 |
| Bayer | 7 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $123 |
| Boehringer Ingelheim | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| Ironwood Pharmaceuticals, Inc | 6 | $103 |
| Astellas Pharma US Inc | 5 | $97 |
| Merck | 5 | $85 |
| Ardelyx, Inc. | 3 | $57 |
| Novartis | 3 | $52 |
| Gilead | 1 | $33 |
| Indivior Inc. | 2 | $33 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Embecta Corp. | 1 | $21 |
| BD | 1 | $19 |
| Optinose US, Inc. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,824 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $45,238 |
| OzempicSemaglutide | 26 | $28,835 |
| FarxigaDapagliflozin Propanediol | 16 | $16,103 |
| Xigduo XrDapaglifloz Propaned/Metformin | 20 | $12,871 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,166 |
| JardianceEmpagliflozin | 11 | $9,784 |
| LinzessLinaclotide | 16 | $8,321 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,796 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 97 | $1,465 |
| Oxycodone Hcl | 50 | $881 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $845 |
| Atorvastatin Calcium | 116 | $591 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 18 | $461 |
| Omeprazole | 45 | $322 |
| Levothyroxine Sodium | 35 | $280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $33 | $45,23812 claims |
| Novo NordiskOzempic | $320 | $28,83526 claims |
| AstraZenecaFarxiga | $473 | $16,10316 claims |
| GSKTrelegy Ellipta | $584 | $10,16617 claims |
| Boehringer IngelheimJardiance | $123 | $9,78411 claims |
| AbbVieLinzess | $761 | $8,32116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in West Haverstraw
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.